The antinuclear antibody test is used to detect the presence of antinuclear antibodies in the blood serum. These are auto antibodies that bind to the content of the cell nucleus. Global antinuclear antibody test market was valued at $0.92 billion in 2017 and is expected to reach $0.23 billion by 2025 with a CAGR of 12.40% during the forecast period from 2019-2025. The factors like growth in health care awareness among people, the increase in the prevalence of autoimmune diseases and government health care insurance & reimbursement policies and the increase in health care expenditure are driving market growth. The factors like lack of skilled professionals, diagnostic errors and stringent regulation for product approval are declining the market growth. Laboratory automation and emerging markets in Asia present are some of the market growth opportunities.
Research Study Objectives:
- Define, estimate, and forecast the Antinuclear Antibody Test market statistics by technique, product, diseases, end user and regions concerning the individual growth drivers, market trends and their contribution toward the Antinuclear Antibody Test market growth
- Provides comprehensive information regarding the key factors influencing the market growth (Drivers, Restraints & Challenges, and Opportunities)
- Estimate & forecast the market size of all the segments concerning geographies including North America, Europe, Asia Pacific (APAC), South America and the Middle East and Africa (MEA).
- Recent competitive developments including M&A (Mergers and Acquisitions), Partnerships, and Product Innovations are provided in the Antinuclear Antibody Test Market Analysis report.
- Analysis and conclusions on the future Antinuclear Antibody Test market outlook.
Top-down and bottom-up approaches are used to validate the Antinuclear Antibody Test Market Size and are used to estimate the size of other dependent submarkets. Key players in the market are identified through various secondary
sources; databases including Bloomberg Businessweek, Hoovers, Factiva, journals and associations and the market revenues are estimated and are thoroughly validated through primary and secondary research. Secondary research involves the study of annual and financial reports of top players in the market, whereas primary research includes extensive interviews with the KoL’s such as CEOs, directors, board members, VP’s, sales managers, engineers, marketing executives, technicians, account managers, investors, strategic decision makers and others. The Antinuclear Antibody Test Market shares and breakdowns are determined using secondary sources and are verified by the primary sources. All possible parameters/factors that are affecting the Antinuclear Antibody Test market demand are covered in the research study are verified through primary research, analysed and interpreted to get the final qualitative and quantitative data. This data is collected and added with detailed analysis from Envision Inteligence and presented in this report.
The scope of the Report
The Antinuclear Antibody Test market segmentation is as follows:
By Technique
- Immunofluorescence Assay
- Multiplex Assay
- Elisa
By Product
- Systems
- Software & Services
- Reagents & Assay Kits
By Diseases
- Sjögren’s Syndrome
- Scleroderma
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
By End User
- Clinical Laboratories
- Physician Office Laboratories
- Hospitals
- Others
Geographical Analysis:
Antinuclear Antibody Test Market is segmented by geography into North America, South America, Europe, APAC and Middle East & Africa. U.S., Canada, Mexico and Costa Rica are analysed under North American region which is usually turning as the hotspot in the market. The South American region is further segregated into Brazil, Argentina, Chile, Columbia and some other emerging economies. In Europe, the market is extensively examined by covering U.K., Germany, France, Italy, Spain, Netherlands, Poland, Switzerland and some other promising economies. APAC is further categorised by countries into China, India, Japan, South Korea, Australia & New Zealand, Malaysia, Singapore and many other emerging nations.
In the Middle East & African region, Saudi Arabia, UAE, Iran, Iraq, Qatar, South Africa, Algeria, Morocco, Nigeria and so on countries are evaluated to understand the market growth lucidly.
Customization Options:
With the given research report, Envision Inteligence offers customisations as per the client’s specific requirements. The following customisation options offered for the Antinuclear Antibody Test Market include:
- Scope Revision
- Geographic Analysis
- Company Profiles
- Historical Data & Forecasting
- Key Contact Persons in companies
Global Antinuclear Antibody Test Market Research Report Includes:
- An executive summary condensing the whole report such that essential authority can rapidly twist up doubtlessly acquainted with brief overview and conclusion.
- To have a complete market analysis through industry value chain analysis, Porter’s Five Force Model, PESTLE, SWOT analysis, and Y-o-Y analysis.
- Regional and global diversity is analysed with the major countries and the unions. Scrutinizing the revenue generation on Year-On-Year
- Identifying DROC in the current market and their impact on altering market dynamics.
- Competitive landscape analysis to identify the merger and acquisition which will have a comparative financial study with significant competitors.
- Expertise investment opportunities by an analyst to the individual and organisation to have a better foothold in the market.
- Identify the latest developments, market shares and strategies that are employed by the significant Antinuclear Antibody Test market players, such as
- ERBA Diagnostics, Inc.
- Antibodies Inc.
- PerkinElmer Germany Diagnostics GmbH
- Immuno Concepts N.A. Ltd.
- Inova Diagnostics, Inc.
- Along with these companies, many other companies are considered in the report while analysing the Global Antinuclear Antibody Test competitive strategies and environment. These companies held substantial share-owning to the nature of the industry whereas, the rest of the market shares are marginal chunks to regional and local level manufacturers. Other players also have considerable presence owing to its robust brand image, geographical reach and stable customer base.
